News
Under the deal to start on July 1st, cash-paying patients can access a month's supply of Wegovy through the Danish ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
The collaboration between HIMS and Novo Nordisk, which began in April 2025, was supposed to be a game-changer for the telehealth company. The partnership promised direct access to Wegovy, Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback